Company logo

ORGO - Organogenesis Holdings Inc.

NASDAQ -> Healthcare -> Drug Manufacturers—Specialty & Generic
Canton, United States
Type: Equity

ORGO price evolution
ORGO
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Current assets
Cash $104.34 $98.83 $89.51 $89.42
Short term investments
Net receivables $82 $89.28 $93.61 $92.02
Inventory $28.25 $27.91 $25.36 $25.54
Total current assets $225.04 $225.57 $216.44 $216.82
Long term investments
Property, plant & equipment $156.35 $159.87 $155.37 $149.48
Goodwill & intangible assets $44.64 $45.87 $47.1 $48.33
Total noncurrent assets $234.98 $237.07 $233.88 $229.28
Total investments
Total assets $460.02 $462.65 $450.31 $446.11
Current liabilities
Accounts payable $30.72 $26.78 $27.39 $30.31
Deferred revenue
Short long term debt $19.71 $19.7 $18.28 $17.17
Total current liabilities $80.51 $81.48 $73.45 $76.08
Long term debt $99.64 $103.11 $104.39 $105.19
Total noncurrent liabilities $100.85 $104.3 $105.58 $106.33
Total debt $119.35 $122.81 $122.67 $122.35
Total liabilities $181.36 $185.78 $179.03 $182.41
Shareholders' equity
Retained earnings -$40.97 -$40.4 -$43.57 -$48.88
Other shareholder equity
Total shareholder equity $278.66 $276.87 $271.28 $263.7
(in millions $) 31 Dec 2023 31 Jan 2023 31 Dec 2021 31 Dec 2020
Current assets
Cash $104.34 $102.48 $114.53 $84.81
Short term investments
Net receivables $82 $89.45 $82.46 $56.8
Inventory $28.25 $24.78 $25.02 $27.8
Total current assets $225.04 $222.61 $226.98 $174.34
Long term investments
Property, plant & equipment $156.35 $145.66 $128.3 $60.07
Goodwill & intangible assets $44.64 $49.56 $54.45 $59.39
Total noncurrent assets $234.98 $226.75 $216.28 $120.15
Total investments
Total assets $460.02 $449.36 $443.26 $294.49
Current liabilities
Accounts payable $30.72 $32.33 $29.34 $23.38
Deferred revenue
Short long term debt $19.71 $16.25 $14.64 $20.29
Total current liabilities $80.51 $75.02 $82 $68.22
Long term debt $99.64 $66.23 $117.66 $64.49
Total noncurrent liabilities $100.85 $108.67 $119.22 $80.19
Total debt $119.35 $123.79 $132.3 $84.77
Total liabilities $181.36 $183.69 $201.22 $148.41
Shareholders' equity
Retained earnings -$40.97 -$45.3 -$60.13 -$153.06
Other shareholder equity
Total shareholder equity $278.66 $265.67 $242.03 $146.08
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Revenue
Total revenue $99.65 $108.53 $117.32 $107.64
Cost of revenue $27.77 $25.79 $26.32 $26.61
Gross Profit $71.88 $82.74 $91 $81.03
Operating activities
Research & development $11.77 $10.47 $10.94 $11.2
Selling, general & administrative $61.38 $64.22 $70.32 $73.83
Total operating expenses $73.23 $74.66 $81.23 $85.01
Operating income -$1.35 $8.08 $9.77 -$3.98
Income from continuing operations
EBIT -$1.29 $8.08 $9.77 -$3.98
Income tax expense -$1.23 $4.47 $3.86 -$1.66
Interest expense $0.5 $0.44 $0.59 $0.65
Net income
Net income -$0.57 $3.17 $5.32 -$2.97
Income (for common shares) -$0.57 $3.17 $5.32 -$2.97
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Revenue
Total revenue $433.14 $450.89 $468.06 $338.3
Cost of revenue $106.48 $105.02 $114.2 $87.32
Gross Profit $326.66 $345.87 $353.86 $250.98
Operating activities
Research & development $44.38 $39.76 $30.74 $20.09
Selling, general & administrative $269.75 $283.81 $250.2 $203.48
Total operating expenses $314.13 $323.57 $280.94 $223.47
Operating income $12.53 $22.3 $72.92 $27.51
Income from continuing operations
EBIT $12.58 $22.29 $71.02 $29.76
Income tax expense $5.45 $4.75 -$31.12 $0.53
Interest expense $2.19 $2.01 $7.24 $11.28
Net income
Net income $4.95 $15.53 $94.9 $17.95
Income (for common shares) $4.95 $15.53 $94.9 $17.95
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Net income -$0.57 $3.17 $5.32 -$2.97
Operating activities
Depreciation $6.33 $5.84 $5.41 $5.86
Business acquisitions & disposals
Stock-based compensation $2.37 $2.42 $2.3 $1.91
Total cash flows from operations $10.61 $16.73 $8.65 -$5.08
Investing activities
Capital expenditures -$3.32 -$5.98 -$7.5 -$7.56
Investments
Total cash flows from investing -$3.32 -$5.98 -$7.5 -$7.56
Financing activities
Dividends paid
Sale and purchase of stock
Net borrowings -$1.78 -$1.44 -$1.02 -$0.94
Total cash flows from financing -$1.78 -$1.44 -$1.05 -$1.24
Effect of exchange rate
Change in cash and equivalents $5.51 $9.32 $0.09 -$13.88
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Net income $4.95 $15.53 $94.9 $17.95
Operating activities
Depreciation $23.45 $18.03 $16.68 $7.47
Business acquisitions & disposals -$3.69
Stock-based compensation $9 $6.55 $3.86 $1.66
Total cash flows from operations $30.92 $24.86 $61.98 $6.8
Investing activities
Capital expenditures -$24.36 -$33.9 -$31.22 -$21.14
Investments
Total cash flows from investing -$24.36 -$33.9 -$31.22 -$24.83
Financing activities
Dividends paid
Sale and purchase of stock $2.07 $2.2 $61.9
Net borrowings -$5.17 -$3.01 -$2.01 -$15.91
Total cash flows from financing -$5.5 -$2.2 -$1.04 $42.47
Effect of exchange rate
Change in cash and equivalents $1.05 -$11.24 $29.72 $24.44
Fundamentals
Market cap $362.43M
Enterprise value $377.45M
Shares outstanding 131.32M
Revenue $433.14M
EBITDA $36.03M
EBIT $12.58M
Net Income $4.95M
Revenue Q/Q -13.73%
Revenue Y/Y -4.15%
P/E ratio 73.28
EV/Sales 0.87
EV/EBITDA 10.48
EV/EBIT 30.00
P/S ratio 0.84
P/B ratio 1.30
Book/Share 2.12
Cash/Share 0.79
EPS $0.04
ROA 1.09%
ROE 1.81%
Debt/Equity 0.65
Net debt/EBITDA 2.14
Current ratio 2.80
Quick ratio 2.44